PER

1.23%

8.0¢ percheron therapeutics limited

Ann: ANP and MCRI new R&D collaboration for ATL1102, page-240

First 240 Last

Share
Profile

Follow
arjay

3,549 Posts.

771

21/07/21

11:36

Post #: 54655919
Share

Originally posted by samfiodiving ↑

I sometimes wonder what sort of investors we have on board when you look at the TU people receive

What sort of DD are some people carrying out on their investment, perhaps they just visit HC and believe all the sunshine and roses that get posted here

For instance you get Gassy coming out with this statement

in 18 months the DMD trial will be over ....I reckon that Imo the trial will not go the full 12 months because of the urgency...
So I think by end of 2022 we will be selling Atl1102 for DMD in Europe and USA... even Australia....
Dmd market will be $4 billion

What a ridiculous statement Gassy i just could not believe what i was reading and the thing is this post got 14thumbs up and 3 great Analysis WHAT LOL

Then we get anp2dollars that comes out with a fact but puts it in a nice way as in

Wouldn't it be fairly unusual to have an early readout on a double-blinded, placebo-controlled trial? I know we got early results on our IIA because that was an open label trial. Correct me if I'm wrong but I doubt we get any early reads on the next trial.

Spot on ANP2 you are correct as far as we know, this is going to be a double blind placebo so there is no way this trial will be finished earlier than expected.

As for selling product by the end of 2022 again laughable we will be lucky if all results come to market by the end of 2023

But once again this is IMHO just like gassy,s

I think the presso today is highlighting a Massive Cr coming and once more IMHO explains the constant selling into in the mid 20s

Why would you sell now, you wouldn't unless you were expecting to have a huge top up at some stage

I could well be wrong and happy to admit it if i am, unlike some here

The Preso looked good obviously $$$ been spent

Question is WHO is it directed towards ( Obviously not a pharma )

Time will tell it always does

SEE HOW WE GO

Expand

For some reason ...I think this play is more than just CR..

Look at the shares that were traded yesterday...

Even if it's a CR...I think it will be with some bonus announcements..

Looks very strange...You saying sell off but Vol had been low ...

I could be wrong ....

Let's see how we go...lol

ANP Price at posting: 19.3¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

MDI

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Bitcoin investors need to know the risks

BHP

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

AII

Almonty locks in govt agreement for tungsten oxide plant in South Korea

ASX hits all time high out the gate on Friday trades following bullish US inflation data

NIM

Nimy to raise $1.21M to explore 'newsy' WA targets

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

IMM

Immutep reports strong response rate from immunotherapies treating carcinomas

SKS

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

There are more pages in this discussion • 48 more messages in this thread...

First 240 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 8.0¢		Change -0.001(1.23%)		Mkt cap ! $72.12M

Open	High	Low	Value	Volume
8.2¢	8.2¢	8.0¢	$63.52K	777.8K

Buyers (Bids)

No.	Vol.	Price($)
2	43377	8.0¢

Sellers (Offers)

Price($)	Vol.	No.
8.2¢	97561	1

View Market Depth

No.	Vol.	Price($)
2	43377	0.080
2	212658	0.078
1	200000	0.077
3	91500	0.076
4	206988	0.075

Price($)	Vol.	No.
0.082	97561	1
0.083	214000	1
0.084	67142	2
0.085	141000	2
0.086	106100	2

Last trade - 16.10pm 12/07/2024 (20 minute delay)

PER (ASX) Chart

Ann: ANP and MCRI new R&D collaboration for ATL1102, page-240

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Bitcoin investors need to know the risks

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Almonty locks in govt agreement for tungsten oxide plant in South Korea

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Nimy to raise $1.21M to explore 'newsy' WA targets

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Immutep reports strong response rate from immunotherapies treating carcinomas

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: ANP and MCRI new R&D collaboration for ATL1102, page-240

Top Stories

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Bitcoin investors need to know the risks

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Almonty locks in govt agreement for tungsten oxide plant in South Korea

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Nimy to raise $1.21M to explore 'newsy' WA targets

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Immutep reports strong response rate from immunotherapies treating carcinomas

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News